Pinnacle Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,429
| Closed | -$1.14M | – | 780 |
|
|
2021
Q1 | $1.14M | Sell |
7,429
-1,100
| -13% | -$168K | 0.02% | 399 |
|
|
2020
Q4 | $1.33M | Sell |
8,529
-685
| -7% | -$107K | 0.03% | 362 |
|
|
2020
Q3 | $1.05M | Buy |
9,214
+200
| +2% | +$22.9K | 0.03% | 360 |
|
|
2020
Q2 | $1.01M | Sell |
9,014
-9,165
| -50% | -$1.03M | 0.03% | 361 |
|
|
2020
Q1 | $1.63M | Sell |
18,179
-1,256
| -6% | -$113K | 0.05% | 278 |
|
|
2019
Q4 | $2.1M | Buy |
19,435
+60
| +0.3% | +$6.49K | 0.05% | 300 |
|
|
2019
Q3 | $1.9M | Buy |
19,375
+5,175
| +36% | +$507K | 0.04% | 314 |
|
|
2019
Q2 | $1.86M | Buy |
14,200
+550
| +4% | +$72K | 0.04% | 316 |
|
|
2019
Q1 | $1.85M | Buy |
13,650
+2,050
| +18% | +$277K | 0.04% | 313 |
|
|
2018
Q4 | $1.13M | Buy |
11,600
+1,500
| +15% | +$146K | 0.03% | 376 |
|
|
2018
Q3 | $1.4M | Buy |
+10,100
| New | +$1.4M | 0.03% | 363 |
|